TODAY'S HEADLINES

FDA warns about Diflucan during pregnancy

FDA is advising "cautious prescribing" of oral fluconazole (Diflucan, Pfizer) for yeast infections during pregnancy, while it evaluates the results of a Danish study. Read more

FDA approves new indication for lung cancer drug

FDA recently approved a new indication for afatinib (Gilotrif, Boehringer Ingelheim) for patients with squamous cell carcinoma of the lung. Here are the top 6 facts to know about Gilotrif. Read more

CONTINUING PHARMACY EDUCATION

The expanding role of direct oral anticoagulants in the management of thromboembolic disease

This month's CE activity is open for pharmacists and pharmacy technicians: "The expanding role of direct oral anticoagulants in the management of thromboembolic disease." Pharmacists and pharmacy technicians can earn up to 2 hours of CPE credit for completing this knowledge-based activity from the University of Connecticut School of Pharmacy and Drug Topics. More

EDITOR'S PICK

Biosimilars pose problems for Medicare beneficiaries

Surprisingly, Medicare beneficiaries are likely to pay much more for biosimilars than the referenced brand medication, according to a new report. Find out why

May 04, 2016

National Managed Care Pharmacy Survey 2016

Your input is needed! Managed Healthcare Executive, in partnership with Access Market Intelligence and the National Institute of Collaborative Healthcare, is seeking your opinion on the current state of pharmacy. Take the survey and you could win a $200 Visa gift card. Answer Now.

Related Articles

FDA warns supplement firms over unapproved ingredient

FDA expands drug to treat NSCLC